PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis
USA - NASDAQ:PRVA - US74276R1023 - Common Stock
22.53 USD
-0.6 (-2.59%)
We assign a fundamental rating of 4 out of 10 to PRVA. PRVA was compared to 100 industry peers in the Health Care Providers & Services industry. While PRVA has a great health rating, there are worries on its profitability. PRVA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PRVA was profitable.
In the past year PRVA had a positive cash flow from operations.
In multiple years PRVA reported negative net income over the last 5 years.
In the past 5 years PRVA always reported a positive cash flow from operatings.
1.2 Ratios
PRVA has a Return On Assets (1.34%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 2.56%, PRVA is in line with its industry, outperforming 58.00% of the companies in the same industry.
PRVA's Return On Invested Capital of 2.45% is in line compared to the rest of the industry. PRVA outperforms 47.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRVA has a Profit Margin (0.89%) which is in line with its industry peers.
In the last couple of years the Profit Margin of PRVA has declined.
Looking at the Operating Margin, with a value of 1.38%, PRVA is in line with its industry, outperforming 45.00% of the companies in the same industry.
PRVA's Operating Margin has declined in the last couple of years.
PRVA has a Gross Margin of 10.17%. This is in the lower half of the industry: PRVA underperforms 75.00% of its industry peers.
PRVA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
The number of shares outstanding for PRVA has been increased compared to 1 year ago.
The number of shares outstanding for PRVA has been increased compared to 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PRVA has an Altman-Z score of 4.34. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
PRVA's Altman-Z score of 4.34 is fine compared to the rest of the industry. PRVA outperforms 79.00% of its industry peers.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.34 |
ROIC/WACC0.27
WACC9.04%
2.3 Liquidity
PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
PRVA has a Current ratio of 1.67. This is in the better half of the industry: PRVA outperforms 62.00% of its industry peers.
A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.67, PRVA is doing good in the industry, outperforming 66.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.00% over the past year.
Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
The Revenue has grown by 19.01% in the past year. This is quite good.
The Revenue has been growing by 17.17% on average over the past years. This is quite good.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%-21.55%
3.2 Future
Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 59.62% on average per year.
Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.27% on average per year.
EPS Next Y53.99%
EPS Next 2Y72.31%
EPS Next 3Y59.62%
EPS Next 5YN/A
Revenue Next Year15.55%
Revenue Next 2Y8.04%
Revenue Next 3Y6.75%
Revenue Next 5Y2.27%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 173.31, PRVA can be considered very expensive at the moment.
Based on the Price/Earnings ratio, PRVA is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
PRVA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.47.
Based on the Price/Forward Earnings ratio of 68.98, the valuation of PRVA can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.42, PRVA is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 173.31 | ||
| Fwd PE | 68.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than 61.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRVA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.98 | ||
| EV/EBITDA | 62.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PRVA's earnings are expected to grow with 59.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.21
PEG (5Y)23.31
EPS Next 2Y72.31%
EPS Next 3Y59.62%
5. Dividend
5.1 Amount
PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PRVA (11/19/2025, 2:58:03 PM)
22.53
-0.6 (-2.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.09%
Inst Owner Change2.17%
Ins Owners1.85%
Ins Owner Change1.92%
Market Cap2.77B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.62
Price Target32.19 (42.88%)
Short Float %2.98%
Short Ratio3.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)1
Avg Revenue beat(2)-10.75%
Min Revenue beat(2)-27.23%
Max Revenue beat(2)5.73%
Revenue beat(4)3
Avg Revenue beat(4)-3.21%
Min Revenue beat(4)-27.23%
Max Revenue beat(4)7.92%
Revenue beat(8)7
Avg Revenue beat(8)-0.25%
Revenue beat(12)9
Avg Revenue beat(12)-3.44%
Revenue beat(16)9
Avg Revenue beat(16)-11.9%
PT rev (1m)3.19%
PT rev (3m)3.12%
EPS NQ rev (1m)-8.57%
EPS NQ rev (3m)-11.08%
EPS NY rev (1m)1.84%
EPS NY rev (3m)-19.27%
Revenue NQ rev (1m)6.37%
Revenue NQ rev (3m)-3.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 173.31 | ||
| Fwd PE | 68.98 | ||
| P/S | 1.35 | ||
| P/FCF | 24.98 | ||
| P/OCF | 24.98 | ||
| P/B | 3.9 | ||
| P/tB | 7.49 | ||
| EV/EBITDA | 62.32 |
EPS(TTM)0.13
EY0.58%
EPS(NY)0.33
Fwd EY1.45%
FCF(TTM)0.9
FCFY4%
OCF(TTM)0.9
OCFY4%
SpS16.64
BVpS5.78
TBVpS3.01
PEG (NY)3.21
PEG (5Y)23.31
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.34 |
F-Score7
WACC9.04%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y53.99%
EPS Next 2Y72.31%
EPS Next 3Y59.62%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%-21.55%
Revenue Next Year15.55%
Revenue Next 2Y8.04%
Revenue Next 3Y6.75%
Revenue Next 5Y2.27%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year534.36%
EBIT Next 3Y107.12%
EBIT Next 5Y64.83%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
What is the valuation status for PRVA stock?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
What is the valuation of PRIVIA HEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 173.31 and the Price/Book (PB) ratio is 3.9.
What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?
The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 53.99% in the next year.